RS

Ray Singh

Active Director Director DIN 07842242
DIN 07842242 First appointment Aug 2017 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Aug 2017
Shareholding value Locked Premium profile

About Ray Singh

Ray Singh has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Megs Pharmaceutical Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07842242
Primary Designation Director
First Appointment 03 Aug 2017
Oldest Company Age 9 yrs

Current companies

Company Designation Appointment Founded Status
Megs Pharmaceutical Limited U74999RJ2017PLC058722
Director 03 Aug 2017 2017 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Megs Pharmaceutical Limited
Premium access

Shareholding and investment profile for Ray Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ray Singh

Ray Singh has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Megs Pharmaceutical Limited. Engaged in General Business. Contributes to corporate operations.

Ray Singh is associated with 1 company as Director.

Ray Singh has expertise in General Business.

Ray Singh has 9 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available